Clinical Trials | March 09, 2022
SRL Diagnostics report indicates women neglect routine tests
Routine tests undertaken by women dropped by 35% in 2020
Routine tests undertaken by women dropped by 35% in 2020
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream
Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home
Study to evaluate effectiveness of hypoglossal nerve stimulation
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death or hospitalization for heart failure, regardless of ejection fraction
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Subscribe To Our Newsletter & Stay Updated
